These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26487886)

  • 1. Nanosizing of drugs: Effect on dissolution rate.
    Dizaj SM; Vazifehasl Zh; Salatin S; Adibkia Kh; Javadzadeh Y
    Res Pharm Sci; 2015; 10(2):95-108. PubMed ID: 26487886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanosizing techniques for improving bioavailability of drugs.
    Al-Kassas R; Bansal M; Shaw J
    J Control Release; 2017 Aug; 260():202-212. PubMed ID: 28603030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of nanosuspensions as a tool to improve drug bioavailability: focus on topical delivery.
    Lai F; Schlich M; Pireddu R; Corrias F; Fadda AM; Sinico C
    Curr Pharm Des; 2015; 21(42):6089-103. PubMed ID: 26503149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanosizing of a drug/carrageenan complex to increase solubility and dissolution rate.
    Dai WG; Dong LC; Song YQ
    Int J Pharm; 2007 Sep; 342(1-2):201-7. PubMed ID: 17560055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics.
    Bhalani DV; Nutan B; Kumar A; Singh Chandel AK
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid dispersions, part II: new strategies in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
    Bikiaris DN
    Expert Opin Drug Deliv; 2011 Dec; 8(12):1663-80. PubMed ID: 21919806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs.
    Zhang X; Xing H; Zhao Y; Ma Z
    Pharmaceutics; 2018 Jun; 10(3):. PubMed ID: 29937483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
    J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Technical Approach of Solubility Enhancement of Poorly Soluble Drugs: Liquisolid Technique.
    Chaudhary N; Tripathi D; Rai AK
    Curr Drug Deliv; 2020; 17(8):638-650. PubMed ID: 32416691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsulation of Solid Dispersion in Solid Lipid Particles for Dissolution Enhancement of Poorly Water-Soluble Drug.
    My Tran KT; Vo TV; Lee BJ; Duan W; Ha-Lien Tran P; Truong-Dinh Tran T
    Curr Drug Deliv; 2018; 15(4):576-584. PubMed ID: 28595530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of self-dispersible dry nanosuspension through wet milling and spray freeze-drying for poorly water-soluble drugs.
    Niwa T; Danjo K
    Eur J Pharm Sci; 2013 Nov; 50(3-4):272-81. PubMed ID: 23907001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of nanosizing on solubility and dissolution rate of poorly soluble pharmaceuticals.
    Murdande SB; Shah DA; Dave RH
    J Pharm Sci; 2015 Jun; 104(6):2094-2102. PubMed ID: 25821105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanosizing of valsartan by high pressure homogenization to produce dissolution enhanced nanosuspension: pharmacokinetics and pharmacodyanamic study.
    Gora S; Mustafa G; Sahni JK; Ali J; Baboota S
    Drug Deliv; 2016; 23(3):940-50. PubMed ID: 24937379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fast-dissolving microparticles fail to show improved oral bioavailability.
    Wong SM; Kellaway IW; Murdan S
    J Pharm Pharmacol; 2006 Oct; 58(10):1319-26. PubMed ID: 17034654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and isolation of pharmaceutical drug nanoparticles.
    Verma V; Ryan KM; Padrela L
    Int J Pharm; 2021 Jun; 603():120708. PubMed ID: 33992712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Oral Bioavailability of Lacidipine Using Nanosuspension Technology: Inferior in vitro Dissolution and Superior in vivo Drug Absorption versus Lacipil®.
    Zhao J; Luo L; Fu Q; Guo B; Li Y; Geng Y; Wang J; Zhang T
    Curr Drug Deliv; 2016; 13(5):764-73. PubMed ID: 25963306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocrystals Technology for Improving Bioavailability of Poorly Soluble Drugs: A Mini-Review.
    Zhou Y; Du J; Wang L; Wang Y
    J Nanosci Nanotechnol; 2017 Jan; 17(1):18-28. PubMed ID: 29616786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
    Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
    J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs.
    Hu J; Johnston KP; Williams RO
    Drug Dev Ind Pharm; 2004 Mar; 30(3):233-45. PubMed ID: 15109023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.